Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Liberty Global Ltd Class C (LBTYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Liberty Global Ltd Class C — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Liberty Global Ltd Class C trades at $8.03 (market cap $2.94B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 2.9× Liberty Global Ltd Class C's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Liberty Global Ltd Class C nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Liberty Global Ltd Class C for 20 Days on average.
| HNGE | LBTYK | |
|---|---|---|
Market Cap | $8.48B | $2.94B |
Volume | 879,799 | 1,441,876 |
Sector | Health | Media |
52-Week High | $105.14 | $12.67 |
52-Week Low | $31.17 | $8.03 |
Typical Hold Time | 0 Days | 20 Days |
Enterprise Value | $8.10B | $9.60B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Liberty Global (LBTYK) trades at $8.41, showing minimal daily movement with a 0.24% gain. The stock faces bearish technical signals but maintains strong analyst support with 69% buy ratings and a $12.67 consensus target. Recent financials show mixed performance with negative net income margins (-62.14%) despite solid gross margins (67.17%), while strategic moves like the Ziggo Group spin-off and AI partnerships aim to unlock value by 2027.
The outlook remains cautiously optimistic given the significant upside to analyst targets and ongoing corporate restructuring. Key risks include persistent profitability challenges and execution risks around the Ziggo listing. The stock's deep value proposition (P/S 0.59, P/B 0.31) offers potential for patient investors despite near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Liberty Global Ltd Class C
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →
